FIG
IRWD icon

Fortress Investment Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Fortress Investment Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-612,383
Closed -$5.1M – 182
2013
Q2 		$5.1M Buy
+612,383
New +$7.42M 0.13% 31

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Fortress Investment Group's IRWD Position: Q3 2013 in Review

Fortress Investment Group sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2013, closing a stake of 612,383 shares — an estimated $5.1M sold.

Fortress Investment Group first reported a position in IRWD in Q2 2013 and held it in 1 quarter. The position peaked at $5.1M in Q2 2013. 124 funds tracked by Wall St. Rank hold IRWD as of Q3 2013.

  • Fortress Investment Group reported no remaining Ironwood Pharmaceuticals position as of Q3 2013 after selling out during the quarter.
  • Fortress Investment Group sold 612,383 Ironwood Pharmaceuticals shares in Q3 2013, an estimated $5.1M.
  • Fortress Investment Group first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 1 quarter.
  • Fortress Investment Group's Ironwood Pharmaceuticals position peaked at $5.1M in Q2 2013.
  • 124 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2013.

Based on Fortress Investment Group's 13F filing for Q3 2013, filed 14 Nov 2013.